Literature DB >> 21448683

["Herpetic keratitis". Various expressions require different therapeutic approaches].

B Seitz1, A Heiligenhaus.   

Abstract

Herpes simplex virus (HSV) is a common cause of keratitis. "Herpetic keratitis" is a chameleon, which is well treatable today if the various types of clinical expression of this disease are known to the ophthalmologist and treatment is adjusted accordingly. Types of expression include 1. epithelial keratitis (dendritica/geographica), 2. stromal keratitis (necrotizing vs. non-necrotizing = "interstitial keratitis"), 3. endotheliitis (=disciform keratitis), 4. neurotrophic keratopathy (=so-called metaherpetic keratitis) and 5. (vascularized) corneal scars. A concomitant ocular hypertension should be treated predominantly non-surgically (no prostaglandin analogues). Topical artificial tears (if necessary with acyclovir ointment at night) in the quiet interval are recommended to limit the tendency towards recurrences. After keratoplasty and in cases of severe recurrences of herpetic keratitis, systemic acyclovir application (2×400 mg/day) for at least 1 year is indispensable! Overall, HSV has lost its "terror" today, even after keratoplasty, given adequate management.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21448683     DOI: 10.1007/s00347-011-2346-5

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  35 in total

1.  Predictors of recurrent herpes simplex virus keratitis. Herpetic Eye Disease Study Group.

Authors: 
Journal:  Cornea       Date:  2001-03       Impact factor: 2.651

2.  Histopathology of herpes zoster ophthalmicus.

Authors:  G Naumann; J D Gass; R L Font
Journal:  Am J Ophthalmol       Date:  1968-04       Impact factor: 5.258

3.  Treatment of HSV-1 stromal keratitis with topical cyclosporin A: a pilot study.

Authors:  A Heiligenhaus; K P Steuhl
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1999-05       Impact factor: 3.117

4.  Herpes simplex virus in primary graft failure.

Authors:  G C Cockerham; A E Krafft; I W McLean
Journal:  Arch Ophthalmol       Date:  1997-05

Review 5.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

6.  Management of acute ulcerative and necrotising herpes simplex and zoster keratitis with amniotic membrane transplantation.

Authors:  A Heiligenhaus; H Li; E E Hernandez Galindo; J M Koch; K-P Steuhl; D Meller
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

7.  [Therapy of herpetic diseases of the anterior eye segment].

Authors:  R Sundmacher
Journal:  Klin Monbl Augenheilkd       Date:  1985-06       Impact factor: 0.700

8.  Randomised double-blind trial of bromovinyldeoxyuridine (BVDU) and trifluorothymidine (TFT) in dendritic corneal ulceration.

Authors:  W J Power; A Benedict-Smith; M Hillery; K Brady; L M Collum
Journal:  Br J Ophthalmol       Date:  1991-11       Impact factor: 4.638

9.  Infection of the corneal endothelium in herpes simplex keratitis.

Authors:  L M Holbach; N Asano; G O Naumann
Journal:  Am J Ophthalmol       Date:  1998-10       Impact factor: 5.258

10.  Prevalence and clinical consequences of herpes simplex virus type 1 DNA in human cornea tissues.

Authors:  Lies Remeijer; Rui Duan; Jessica M van Dun; Mark A Wefers Bettink; Albert D M E Osterhaus; Georges M G M Verjans
Journal:  J Infect Dis       Date:  2009-07-01       Impact factor: 5.226

View more
  9 in total

1.  [The German Acanthamoeba keratitis register: Initial results of a multicenter study].

Authors:  L Daas; N Szentmáry; T Eppig; A Langenbucher; A Hasenfus; M Roth; M Saeger; B Nölle; B Lippmann; D Böhringer; T Reinhard; C Kelbsch; E Messmer; U Pleyer; S Roters; A Zhivov; K Engelmann; J Schrecker; L Zumhagen; H Thieme; R Darawsha; T Meyer-Ter-Vehn; B Dick; I Görsch; M Hermel; M Kohlhaas; B Seitz
Journal:  Ophthalmologe       Date:  2015-09       Impact factor: 1.059

2.  [Ping-pong transmission of herpes simplex virus 1 following corneal transplantation].

Authors:  E Stavridis; Z Gatzioufas; A Hasenfus; M Sauter; S Smola; B Seitz
Journal:  Ophthalmologe       Date:  2012-10       Impact factor: 1.059

3.  [Prophylaxis and management of complications in penetrating keratoplasty].

Authors:  B Seitz; M El-Husseiny; A Langenbucher; N Szentmáry
Journal:  Ophthalmologe       Date:  2013-07       Impact factor: 1.059

4.  [Therapy refractory stromal Herpes keratitis under aciclovir].

Authors:  C Spira; N Szentmáry; A Hasenfus; M Sauter; S Smola; B Seitz
Journal:  Ophthalmologe       Date:  2014       Impact factor: 1.059

5.  [Peracute corneal alterations and anterior chamber reaction following refractive surface ablation].

Authors:  P Franko Zeitz; S Brettl; J Zeitz
Journal:  Ophthalmologe       Date:  2014-09       Impact factor: 1.059

6.  [Photodynamic therapy for infectious keratitis].

Authors:  N Szentmáry; S Goebels; M Bischoff; B Seitz
Journal:  Ophthalmologe       Date:  2012-02       Impact factor: 1.059

Review 7.  [Secondary open-angle glaucoma: uveitic secondary glaucoma, steroid-induced glaucoma, posttraumatic and postoperative glaucoma, tumor-related glaucoma and glaucoma due to elevated episcleral venous pressure].

Authors:  Roman Greslechner; Horst Helbig; Detlev Spiegel
Journal:  Ophthalmologe       Date:  2022-04-26       Impact factor: 1.059

8.  [Bilateral vascularized disciform corneal scar of herpetic origin in a child].

Authors:  M Fiorentzis; N Szentmáry; B Seitz
Journal:  Ophthalmologe       Date:  2015-02       Impact factor: 1.059

9.  Repeat corneal graft failure due to graft-to-host herpetic infection.

Authors:  Zisis Gatzioufas; Andrea Hasenfus; Balasz Gyongyossy; Evangelos Stavridis; Marlies Sauter; Sigrun Smola; Berthold Seitz
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-01-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.